Matt OBrien
Stock Analyst at Piper Sandler
(3.01)
# 1,463
Out of 5,041 analysts
8
Total ratings
87.5%
Success rate
40.53%
Average return
Main Sectors:
Stocks Rated by Matt OBrien
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HTFL HeartFlow | Initiates: Overweight | $38 | $40.79 | -6.84% | 1 | Sep 2, 2025 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $55 → $62 | $82.93 | -25.24% | 6 | Oct 29, 2020 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $70 → $90 | $15.00 | +500.00% | 1 | Feb 25, 2020 |
HeartFlow
Sep 2, 2025
Initiates: Overweight
Price Target: $38
Current: $40.79
Upside: -6.84%
Merit Medical Systems
Oct 29, 2020
Maintains: Overweight
Price Target: $55 → $62
Current: $82.93
Upside: -25.24%
Tandem Diabetes Care
Feb 25, 2020
Maintains: Overweight
Price Target: $70 → $90
Current: $15.00
Upside: +500.00%